Cited by 713Hormonal and reproductive studiesProstate Cancer Treatment and ResearchMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden, Ernani Luis, Morgentaler, Abraham·2004·New England Journal of Medicine

DOI 10.1056/nejmra022251

Open this paper in CoChat — free account

Abstract

Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.

Integrity signals

Registry

Crossref · 10.1056/nejmra022251

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
STUDIES ON PROSTATIC CANCER
Huggins, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,694
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160073037 · Cited by 1,076
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 744
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins, C., & Hodges, C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 637

Show all 77 references

Research works printed but not linked: 11

10.1210/jc.86.2.724 · DOI · Paper page
10.1210/jc.82.6.1661 · DOI
10.1210/jc.83.10.3443 · DOI
10.1210/jc.82.11.3793 · DOI
10.1210/jc.87.1.136 · DOI
10.1210/jc.87.4.1467 · DOI
Barrett-Connor EL, 1995, Diabetes Metab, 21, 156
2002, Endocr Rep, 2, 1
10.1210/jc.86.6.2380 · DOI
Westaby D, 1977, Lancet, 2, 262
10.1345/aph.1A020 · DOI · Paper page

Sorted by citations

Items 201–300 of 713

Mechanism of the Tissue-Specific Action of the Selective Androgen Receptor Modulator S-101479
Furuya, K., Yamamoto, N., Ohyabu, Y., Morikyu, T., Ishige, H., Albers, M., & Endo, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00885 · Cited by 38
Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy
Parsons, J. K., Carter, H. B., Platz, E. A., Wright, E. J., Landis, P. K., & Metter, E. J. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00880-3 · Cited by 37
Alendronate for osteoporosis in men with androgen-repleted hypogonadism
Shimon, I., Eshed, V., Doolman, R., Sela, B., Karasik, A., & Vered, I. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1879-3 · Cited by 37
Guilt by Association: A Historical Perspective on Huggins, Testosterone Therapy, and Prostate Cancer
Morgentaler, A. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00889.x · Cited by 36
Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices
Miner, M. M., Canty, D. J., & Shabsigh, R. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1914 · Cited by 35
Controversies and Advances With Testosterone Therapy: A 40-Year Perspective
Morgentaler, A. (2015) · Urology · doi:10.1016/j.urology.2015.11.034 · Cited by 35
Hormone‐related diseases and prostate cancer: An English national record linkage study
Watts, E. L., Goldacre, R., Key, T. J., Allen, N. E., Travis, R. C., & Perez‐Cornago, A. (2019) · International Journal of Cancer · doi:10.1002/ijc.32808 · Cited by 35
The male biological clock
Lambert, S. M., Masson, P., & Fisch, H. (2006) · World Journal of Urology · doi:10.1007/s00345-006-0130-y · Cited by 35
“from hypogonadism (deWned as serum total testosterone levels lower than 325 ng per deciliter) [7].”
Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem
Irwig, M. S., Fleseriu, M., Jonklaas, J., Tritos, N. A., Yuen, K. C. J., Correa, R. R., Elhomsy, G. C., Garla, V. V., Jasim, S., Soe, K. K., et al. (2020) · Endocrine Practice · doi:10.4158/ps-2019-0540 · Cited by 35
Guideline for Male Testosterone Therapy: A Clinician’s Perspective
Morgentaler, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2629 · Cited by 34
Goodbye Androgen Hypothesis, Hello Saturation Model
Morgentaler, A. (2012) · European Urology · doi:10.1016/j.eururo.2012.06.027 · Cited by 34
Androgen deficiency in older men: Indications, advantages, and pitfalls of testosterone replacement therapy
McGill, J., Shoskes, D. A., & Sabanegh, E. S. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.12010 · Cited by 33
Testosterone Supplementation and Cognitive Functioning in Men—A Systematic Review and Meta-Analysis
Buskbjerg, C. R., Gravholt, C. H., Dalby, H. R., Amidi, A., & Zachariae, R. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00119 · Cited by 37
The Current Status of Therapy for Symptomatic Late-Onset Hypogonadism with Transdermal Testosterone Gel
Ebert, T., Jockenhövel, F., Morales, Á., & Shabsigh, R. (2004) · European Urology · doi:10.1016/j.eururo.2004.09.015 · Cited by 33
Biochemical endocrinology of the hypogonadal male
Belchetz, P. E., Barth, J. H., & Kaufman, J. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010150 · Cited by 32
Pharmacokinetics and Pharmacodynamics of LGD-3303 [9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3 H-pyrrolo-[3,2-f]quinolin-7(6 H)-one], an Orally Available Nonsteroidal-Selective Androgen Receptor Modulator
Vajda, E. G., LÓPEZ, F. J., Rix, P. J., Hill, R., Chen, Y., Lee, K., O’Brien, Z., Chang, W. Y., Meglasson, M. D., & Lee, Y.-H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146811 · Cited by 33
A 66-Year-Old Man With Sexual Dysfunction
Morgentaler, A. (2004) · JAMA · doi:10.1001/jama.291.24.2994 · Cited by 32
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators
Hamann, L. G., Manfredi, M. C., Sun, C., Krystek, S. R., Huang, Y., Bi, Y., Augeri, D. J., Wang, T., Zou, Y., Betebenner, D. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.076 · Cited by 31
Targeting dysregulated phago-/auto-lysosomes in Sertoli cells to ameliorate late-onset hypogonadism
Deng, Z., Zhao, L., Li, S., Chen, X., Ling, X., Zheng, J., Yu, K., Xu, J., Yao, C., Han, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00614-2 · Cited by 32
Prostate‐specific antigen ( PSA ) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment
Raynaud, J., Gardette, J., ROLLET, J., & Legros, J. (2013) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11514.x · Cited by 30
Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging
Golestani, R., Slart, R. H. J. A., Dullaart, R. P. F., Glaudemans, A. W. J. M., Zeebregts, C. J., Boersma, H. H., Tio, R. A., & Dierckx, R. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02642.x · Cited by 32
Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression
Shimon, I., Benbassat, C. A., Tzvetov, G., & Grozinsky‐Glasberg, S. (2010) · Pituitary · doi:10.1007/s11102-010-0251-6 · Cited by 30
Current and future testosterone delivery systems for treatment of the hypogonadal male
Pfeil, E., & Dobs, A. S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.471 · Cited by 30
Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone
Wang, Y.-J., Zhan, J.-K., Huang, W., Wang, Y., Liu, Y., Wang, S., Tan, P., Tang, Z.-Y., & Liu, Y.-S. (2013) · International Journal of Endocrinology · doi:10.1155/2013/570413 · Cited by 29
Testosterone and Prostate Cancer: What are the Risks for Middle-Aged Men?
Morgentaler, A. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.02.002 · Cited by 29
“A second study reported similar reassuring results in 10 men who had also undergone radical prostatectomy with undetectable PSA.29 Mean total T increased from 197 ng/dL to 591 ng/dL, and symptoms of hypogonadism improved.”
Influential
Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).
Karamanolakis, D., Lambou, T., Bogdanos, J., Milathianakis, C., Sourla, A., Lembessis, P., Halapas, A., Pissimissis, N., Dessypris, N., Petridou, E. T., et al. (2006) · PubMed · Cited by 29
Depression, Testosterone Concentration, Sexual Dysfunction and Methadone Use Among Men with Hypogonadism and HIV Infection
Lari, M. A., Parsa, N., Marzban, M., Shams, M., & Faramarzi, H. (2012) · AIDS and Behavior · doi:10.1007/s10461-012-0234-x · Cited by 29
Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care
Feldman, J., & Safer, J. D. (2009) · International Journal of Transgenderism · doi:10.1080/15532730903383757 · Cited by 31
Effect of testosterone undecanoate on hematological profiles, blood lipid and viscosity and plasma testosterone level in castrated rabbits
Zhao, C., Moon, D. G., & Park, J. K. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.507 · Cited by 29
Androgens and male aging: current evidence of safety and efficacy
Gooren, L. J. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.4 · Cited by 29
Testim® 1% testosterone gel for the treatment of male hypogonadism
Bouloux, P. M. (2005) · Clinical Therapeutics · doi:10.1016/j.dinthera.2005.02.015 · Cited by 29
[Erectile dysfunction: a sentinel symptom?].
Costa, P., Grivel, T., Giuliano, F., Pinton, P., Amar, E., & Lemaire, A. (2005) · PubMed · Cited by 28
Clinical aspects of infertile 47,XYY patients: a retrospective study
Boroujeni, P. B., Sabbaghian, M., Vosough, A., Moradi, S. Z., Almadani, N., Lashkari, F. M., Zamanian, M. R., & Meybodi, A. M. (2017) · Human Fertility · doi:10.1080/14647273.2017.1353143 · Cited by 28
Role of Testosterone in the Treatment of Cardiovascular Disease
Webb, C. M., & Collins, P. D. (2017) · European Cardiology Review · doi:10.15420/ecr.2017:21:1 · Cited by 31
Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial
Masterson, T. A., Molina, M. L., Ibrahim, E., & Ramasamy, R. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.08.009 · Cited by 28
Hypogonadism in male outpatients with sarcoidosis
Spruit, M. A., Thomeer, M., Gosselink, R., Wuyts, W. A., Herck, E. V., Bouillon, R., Demedts, M., & Decramer, M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.009 · Cited by 28
Differing levels of testosterone and the prostate: a physiological interplay
Goldenberg, S. L., Koupparis, A. J., & Robinson, M. E. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.79 · Cited by 27
Turning conventional wisdom upside‐down
Morgentaler, A. (2011) · Cancer · doi:10.1002/cncr.25975 · Cited by 28
Testosterone deficiency: myth, facts, and controversy.
Miner, M. M., Barkin, J., & Rosenberg, M. T. (2014) · PubMed · Cited by 27
Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility
Fink, J. E., Schoenfeld, B. J., Hackney, A. C., Maekawa, T., & Horie, S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1863783 · Cited by 27
The Novel Non-steroidal Selective Androgen Receptor Modulator S-101479 Has Additive Effects with Bisphosphonate, Selective Estrogen Receptor Modulator, and Parathyroid Hormone on the Bones of Osteoporotic Female Rats
Furuya, K., Yamamoto, N., Ohyabu, Y., Makino, A., Morikyu, T., Ishige, H., Kuzutani, K., & Endo, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00054 · Cited by 27
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Curtis, J. R., Weinstein, R. S., & Saag, K. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50046-x · Cited by 27
Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator
Piu, F., Gardell, L. R., Son, T., Schlienger, N., Lund, B. W., Schiffer, H. H., Vanover, K. E., Davis, R. E., Olsson, R., & Bradley, S. R. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.11.001 · Cited by 27
Sex hormone replacement therapy in periodontology—A systematic review
Chaves, J. D. P., Figueredo, T. F. M., Warnavin, S. V. S. C., Pannuti, C. M., & Steffens, J. P. (2019) · Oral Diseases · doi:10.1111/odi.13059 · Cited by 27
Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology
Shimko, K. M., Piatkowski, T. M., Thomas, K. V., Speers, N., Brooker, L., Tscharke, B. J., & O'Brien, J. W. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126340 · Cited by 27
Serum testosterone levels correlate with haemoglobin in middle‐aged and older men
Yeap, B. B., Beilin, J., Shi, Z., Knuiman, M. W., Olynyk, J. K., Bruce, D. G., & Milward, E. A. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01789.x · Cited by 26
Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men
Bendre, S. V., & Murray, P. J. (2015) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000155 · Cited by 26
The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis
Félix-Patrício, B., Miranda, A. F., Medeiros, J. L., GALLO, C. B. M., Gregório, B. M., de Souza, D. B., Costa, W. S., & Sampaio, F. J. B. (2017) · International braz j urol · doi:10.1590/s1677-5538.ibju.2016.0484 · Cited by 26
Management of the Cardinal Features of Andropause
Mooradian, A. D., & Korenman, S. G. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132252.80403.c9 · Cited by 26
Prostatic Specific Antigen in Patients with Hypogonadism: Effect of Testosterone Replacement
El‐Sakka, A. I., Hassoba, H. M., Elbakry, A., & Hassan, H. A. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.20233.x · Cited by 26
Androgen Replacement in Men Undergoing Treatment for Prostate Cancer
Rhoden, E. L., Averbeck, M. A., & Telöken, P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00925.x · Cited by 26
Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men
Kirisawa, T., Ichihara, K., Sakai, Y., Morooka, D., 伊與木, 貴., & Masumori, N. (2021) · Sexual Medicine · doi:10.1016/j.esxm.2020.100306 · Cited by 25
The role of serum testosterone and dehydroepiandrosterone sulfate in kidney function and clinical outcomes in chronic kidney disease: a systematic review and meta-analysis
van der Burgh, A. C., Khan, S. R., Neggers, S. J. C. M. M., Hoorn, E. J., & Chaker, L. (2022) · Endocrine Connections · doi:10.1530/ec-22-0061 · Cited by 26
Advances in male hormone substitution therapy
Qoubaitary, A., Swerdloff, R. S., & Wang, C. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1493 · Cited by 25
Dihydrotestosterone stimulates aldosterone secretion by H295R human adrenocortical cells
Yanes, L. L., & Romero, D. G. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.020 · Cited by 25
Testosterone and coronary artery disease in men
Webb, C. M., & Collins, P. D. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.03.029 · Cited by 25
Aging and exercise training reduce testes microvascular P o 2and alter vasoconstrictor responsiveness in testicular arterioles
Dominguez, J. M., Davis, R. T., McCullough, D. J., Stabley, J. N., & Behnke, B. J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00203.2011 · Cited by 25
Testosterone therapy for men at risk for or with history of prostate cancer
Morgentaler, A. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0004-y · Cited by 25
Dihydrotestosterone treatment rescues the decline in protein synthesis as a result of sarcopenia in isolated mouse skeletal muscle fibres
Wendowski, O., Redshaw, Z., & Mutungi, G. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12122 · Cited by 25
Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men
Alder, N. J., Keihani, S., Stoddard, G. J., Myers, J. B., & Hotaling, J. M. (2018) · British Journal of Urology · doi:10.1111/bju.14390 · Cited by 24
One‐Year Efficacy and Safety Study of a 1.62% Testosterone Gel in Hypogonadal Men: Results of a 182‐Day Open‐Label Extension of a 6‐Month Double‐Blind Study
Kaufman, J. M., Miller, M. G., Fitzpatrick, S. B., McWhirter, C. L., & Brennan, J. J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02630.x · Cited by 25
HIV and prostate cancer: a systematic review of the literature
Silberstein, J., Downs, T. M., Lakin, C., & Kane, C. J. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.44 · Cited by 25
Hypogonadism in the man with erectile dysfunction: What to look for and when to treat
Lazarou, S., & Morgentaler, A. (2005) · Current Urology Reports · doi:10.1007/s11934-005-0044-z · Cited by 24
ORIGINAL RESEARCH—ENDOCRINOLOGY: Comparison of Free Testosterone Results by Analog Radioimmunoassay and Calculated Free Testosterone in an Ambulatory Clinical Population
Moreno, S. A., Shyam, A., & Morgentaler, A. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01473.x · Cited by 33
Controversies in Sexual Medicine
Jannini, E. A., Gravina, G. L., Mortengaler, A., Morales, Á., Incrocci, L., & Hellstrom, W. J. G. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02233.x · Cited by 24
Testosterone and cardiovascular risk—deciphering the statistics
Morgentaler, A., & Kacker, R. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.24 · Cited by 24
The effects of opioids on the endocrine system: an overview
Ali, K., Raphael, J. H., Khan, S., Labib, M. H., & Duarte, R. V. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134299 · Cited by 24
Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice
Naeyer, H. D., Lamon, S., Russell, A. P., Everaert, I., Spaey, A. D., Vanheel, B., Taes, Y., & Derave, W. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2800-y · Cited by 24
Testosterone therapy and prostate cancer—safety concerns are well founded
Klotz, L. H. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.338 · Cited by 24
Reversible, Non-Barrier Male Contraception: Status and Prospects
Hoesl, C. E., Saad, F., van Poppel, M. N. M., & Altwein, J. E. (2005) · European Urology · doi:10.1016/j.eururo.2005.03.010 · Cited by 24
The male biological clock is ticking: a review of the literature
Pasqualotto, F. F., Júnior, E. B., & Pasqualotto, E. B. (2008) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802008000300012 · Cited by 24
Profile of Serum Testosterone Levels after Application of Testosterone Ointment (Glowmin) and Its Clinical Efficacy in Late-Onset Hypogonadism Patients
Amano, T., Imao, T., Takemae, K., Iwamoto, T., Yamakawa, K., Baba, K., Nakanome, M., Sugimori, H., Tanaka, T., Yoshida, K., et al. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00689.x · Cited by 24
Osteoporosis in men
Binkley, N. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000400021 · Cited by 24
Testosterone Replacement Therapy for Male Aging: ASA Position Statement
(2006) · Journal of Andrology · doi:10.1002/j.1939-4640.2006.tb01177.x · Cited by 23
A Rare Cause of Hypertestosteronemia in a 68‐Year‐Old Patient: A Leydig Cell Tumor Due to a Somatic GNAS (Guanine Nucleotide‐Binding Protein, Alpha‐Stimulating Activity Polypeptide 1)–Activating Mutation
Libé, R., Fratticci, A., Lahlou, N., Jornayvaz, F. R., Tissier, F., Louiset, E., Guibourdenche, J., Vieillefond, A., Zerbib, M., & Bertherat, J. Y. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.013441 · Cited by 22
Dermatologic manifestations of hypopituitarism
Geller, J. L., & Braunstein, G. D. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.04.014 · Cited by 22
Men’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
Miner, M. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.003 · Cited by 21
The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study
Alwani, M. M., Al‐Zoubi, R. M., Al-Qudimat, A. R., Yassin, A. A., Aboumarzouk, O. M., Al‐Rumaihi, K., Talib, R. A., & Al-Ansari, A. A. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102748 · Cited by 21
Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy
García-Cruz, E., Huguet, J., Piqueras, M., Márquez, M. P., Peri, L. L., Izquierdo, L., Franco, A., Álvarez-Vijande, R., Ribal, M. J., & Alcaraz, A. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0741-9 · Cited by 21
Testosterone deficiency syndrome: Treatment and cancer risk
Raynaud, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.014 · Cited by 21
Testosterone and Coronary Artery Disease
Schwarcz, M., & Frishman, W. H. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181e84673 · Cited by 21
Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
Hassan, J., & Barkin, J. (2016) · PubMed · Cited by 21
Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
D, R. S. M., Brock, G. B., Gutkin, S. W., & Sorsaburu, S. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02119.x · Cited by 21
Androgen deficiency and hormone‐replacement therapy
Isidori, A. M., Greco, E. A., & Aversa, A. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05603.x · Cited by 21
A Novel Synthetic Androgen Receptor Ligand, S42, Works as a Selective Androgen Receptor Modulator and Possesses Metabolic Effects with Little Impact on the Prostate
Min, L., Yanase, T., Tanaka, T., Fan, W., Nomura, M., Kawate, H., Okabe, T., Takayanagi, R., & Nawata, H. (2009) · Endocrinology · doi:10.1210/en.2009-0405 · Cited by 21
Selective androgen receptor modulators for the treatment of late onset male hypogonadism
Dalton, J. T., Coss, C. C., Jones, A., Hancock, M., & Steiner, M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122339 · Cited by 22
Testosterone replacement therapy and prostate cancer: A word of caution
Brand, T. C., Canby‐Hagino, E., & Thompson, I. M. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0004-x · Cited by 21
Feedback Inhibition of Gonadotropins by Testosterone in Men With Hypogonadotropic Hypogonadism: Comparison to the Intact Pituitary‐Testicular Axis in Primary Hypogonadism
Shimon, I., Lubina, A., Gorfine, M., & Ilany, J. (2006) · Journal of Andrology · doi:10.2164/jandrol.05140 · Cited by 21
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3
Duschek, E. J. J., Gooren, L. J., & Netelenbos, J. C. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.08.011 · Cited by 21
Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel
Stahlman, J., Britto, M. R., Fitzpatrick, S. B., McWhirter, C. L., Testino, S. A., Brennan, J. J., & ZumBrunnen, T. L. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.652731 · Cited by 21
Diminution du désir sexuel et déficit en testostérone chez l’homme
Lejeune, H., Huyghe, É., & Droupy, S. (2013) · The French Journal of Urology · doi:10.1016/j.purol.2013.01.019 · Cited by 21
Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone
Hohl, A., Marques, M. O. T., Coral, M. H. C., & Walz, R. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800013 · Cited by 20
Clinical applications of centrally acting agents in male sexual dysfunction
Hellstrom, W. J. G. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.18 · Cited by 20
Medical Implications of the Male Biological Clock
Lewis, B. H., Legato, M. J., & Fisch, H. (2006) · JAMA · doi:10.1001/jama.296.19.2369 · Cited by 19
Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis
Aghazadeh, M. A., Pastuszak, A. W., Johnson, W. G., McIntyre, M. G., Hsieh, T., & Lipshultz, L. I. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.01.038 · Cited by 19
Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature
Sodi, R., Fikri, R., Diver, M. J., Ranganath, L. R., & Vora, J. P. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563053492784 · Cited by 19
The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
Zitzmann, M., Cremers, J. F., Krallmann, C., & Kliesch, S. (2022) · The Aging Male · doi:10.1080/13685538.2022.2063830 · Cited by 20
Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS)
Kaplan, S. A., O’Neill, E. A., Lowe, R., Hanson, M. E., & Meehan, A. G. (2013) · The Aging Male · doi:10.3109/13685538.2013.773421 · Cited by 19
Androgens, Exercise Capacity, and Muscle Function in Cystic Fibrosis
Barry, P. J., Waterhouse, D. F., Reilly, C. M., McKenna, T. J., McKone, E. F., & Gallagher, C. G. (2008) · CHEST Journal · doi:10.1378/chest.08-1091 · Cited by 19
Testosterone replacement in elderly men.
Baum, N. H., & Crespi, C. A. (2007) · PubMed · Cited by 19

Authors: Rhoden, E. L., & Morgentaler, A.
Affiliations: Beth Israel Deaconess Medical Center (US)
ORCID: Morgentaler, Abraham
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-01-29
Volume: 350
Issue: 5
Pages: 482-492
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra022251
OpenAlex: W2120158027
Cited by: 705
References: 77
Citations by year: 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 22 · 2015: 36 · 2014: 30 · 2013: 35 · 2012: 44
FWCI: 9.78
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: testosterone replacement therapy, risk, prostate cancer, older men, monitoring, androgen therapy, hypogonadism
MeSH terms: Cardiovascular Diseases, Humans, Hypogonadism, Lipids, Male, Polycythemia, Prostatic Diseases, Risk Factors, Testosterone, Drug Monitoring, Prostate-Specific Antigen, Age Distribution, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risks of testosterone-replacement therapy and recommendations for monitoring.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks